C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.920
-0.140 (-3.45%)
At close: Jul 13, 2026, 4:00 PM EDT
3.860
-0.060 (-1.53%)
Pre-market: Jul 14, 2026, 4:20 AM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $433.42 million as of July 13, 2026. Its market cap has increased by 301.58% in one year.
Market Cap
433.42M
Enterprise Value
223.60M
1-Year Change
301.58%
Ranking
Category
Stock Price
$3.92
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $433.42M, a decrease of -43.91%. That is a compound annual growth rate of -9.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 433.42M | 134.15% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 472.44M |
| Ovid Therapeutics | 470.33M |
| Artiva Biotherapeutics | 468.39M |
| Benitec Biopharma | 461.04M |
| Sagimet Biosciences | 455.11M |
| Larimar Therapeutics | 446.76M |
| Eupraxia Pharmaceuticals | 437.08M |
| Silence Therapeutics | 429.36M |